The architecture behind the signal-density frontier
⭐ The Nano-Bio-Info Architecture

A software-defined electrochemical sensing architecture for biological measurements

Guanine replaces hardware-bound biological measurement with a programmable signal architecture—enabling high-multiplex, high-sensitivity, multi-omic measurement using a compact electrochemical core.

The platform is built on a patent-granted synthetic quadruplex oligonucleotide nanomaterial that enables dense, reversible signal encoding at scale. This material foundation is what allows biological information to be amplified, encoded, and measured within a single architecture.

⭐ Why Biological Measurement Never Had a Moore’s Law

Biology lacked the conditions required for scaling

Computing, communications, and digital imaging each benefited from a common pattern: a standardized signal primitive, a scalable address space, and a control layer capable of preserving performance as systems grew.

Computing scaled with transistors. Imaging scaled with pixels. Telecommunications scaled with bandwidth. Biological measurement lacked a standardized signal primitive and never developed a Moore’s Law.

Biological measurement fragmented into separate modality stacks. DNA required amplification systems. Proteins required binding-and-optics workflows. Metabolites required analytical chemistry platforms. Cells required culture or imaging systems. Each stack was constrained by tradeoffs between sensitivity, speed, multiplexing, cost, and deployment.

These are not biological limits. They are architectural constraints.

Performance improved only within isolated silos. PCR scaled sensitivity. NGS scaled read depth. LC-MS scaled analytical precision. None created a general-purpose, low-cost, programmable measurement architecture across analyte classes. Sensitivity, multiplexing, speed, cost, analyte diversity, and portability remained in tension. The underlying frontier did not move.

Transistors to signal density

Evolution from direct detection to programmable biological measurement
⭐ A Scaling Law for Biological Measurement

Biological measurement can scale across dimensions

Guanine introduces signal density as the primary scaling mechanism. Each analyte is converted into a dense, encoded electrical signal—measured and resolved through software rather than hardware expansion.

Guanine is built around a different premise: biological measurement can scale when signal becomes the unit of engineering. By combining a multi-analyte electrochemical signal primitive, a combinatorial address space for multiplexing, a control layer that stabilizes signal as density increases, and integrated cartridge workflows, Guanine shifts measurement from chemistry-bound workflows to signal-defined infrastructure.

Legacy systems scale by adding hardware. Guanine scales by increasing signal density.

• Capability increases without adding system complexity.

• Multiplexing expands without new instrumentation.

• Signal strength scales with encoding, not enzymatic amplification.

This enables combinations that existing systems cannot achieve: high multiplex with low cost, high sensitivity with rapid turnaround, multi-analyte measurement from a single sample, and functional time-series measurement within a single test.

Not an incremental improvement—a transition from fixed diagnostic systems to programmable measurement infrastructure.

Moore’s Law was not just smaller components. It was a system architecture that allowed capability to compound.


⭐ The Two Scaling Frontiers

Biological measurement requires simultaneous increases in signal density and signal strength

Signal density defines how many independent measurements can be made in a single sample. Signal strength defines whether those measurements are detectable at clinically relevant abundance. Legacy systems typically improve one at the expense of the other. Guanine is designed to increase both.



Signal Density Frontier

A larger address space within a fixed sensing architecture

In the Guanine architecture, measurement capability grows with tag identity, waveform state, and electrode count. Capability expands inside a fixed electrochemical core rather than requiring a new hardware stack for each gain in functionality.

Composite Multiplex Encoding (CME) transforms multiplexing from fixed assay channels into an address space. Each analyte can be represented by a separable signal signature built across tag, waveform, and electrode position.

Signal Density = 4 tags × 9 encoding states × 36 electrodes
= 1,296 addresses
Signal density defines how many independent measurements can be made per sample without proportionally increasing hardware complexity.
Signal density and signal resolution across measurement architectures
Signal Fidelity Frontier

High fidelity per analyte without sacrificing multiplex capacity

Legacy multiplex systems face a structural constraint: as multiplexing increases, sensitivity typically decreases. Microarrays distribute signal across many targets, limiting detection of low-abundance proteins. Sequencing-based systems improve sensitivity, but at the cost of capital complexity, workflow time, and centralized infrastructure.

Guanine removes this constraint by increasing signal fidelity per analyte while preserving multiplex capacity. Each target is bound to a microparticle carrying a high density of reversible electroactive tags, generating a strong electrical signal after filter concentration, selective lysis, and magnetic purification.

Signal Fidelity ∝ Volume × Enrichment × Tag Density × Stability
Legacy systems distribute signal across targets. Guanine concentrates signal per target while preserving the address space—enabling high sensitivity and high multiplexing simultaneously.
Composite encoding produces distinct signal signatures

⭐ Core Signal Architecture

A layered system that converts biological targets into structured electrical signals

Guanine converts biological measurement into a signal-driven system through linked layers: capture, sample conditioning, signal amplification, magnetic concentration, composite encoding, and adaptive waveform control.

These are not separate assay tricks. They are interacting architectural layers that allow signal density and signal strength to scale together within a single sensing architecture.

Core signal architecture diagram

⭐ The Core Technology Primitives

Each primitive contributes to one or both scaling dimensions

The system is built from a small number of recurring primitives. Some expand address space. Some increase detectable signal. Together they create a programmable electrochemical measurement stack.



Quadruplex Signal Tags

A multi-analyte signal primitive with strong, reversible output

At the core of the system is a synthetic electroactive quadruplex tag engineered to produce a distinct electrical signal. Unlike conventional labels that produce a single fragile signal per event, these tags are reversible, stable, and stackable at high density.

This changes the scaling logic of sensitivity. Instead of amplifying the number of target copies, Guanine amplifies the signal generated per target. A single analyte can be linked to dense microparticle-bound tag populations, enabling strong readout without enzymatic amplification.

Primary role: signal strength
Secondary role: signal density through standardized tag identity
Quadruplex oxo tag graph

CME

A multiplex address space built from encoded signal states

Multiplexing in legacy systems is constrained by fixed channels. CME replaces this with composite encoding across tag identity, waveform state, and electrode location. The result is an address space rather than a fixed panel.

Guanine does not simply add more analytes. It creates a signal framework in which many analytes can coexist, be separated, and be computationally decoded inside the same physical system.

Primary role: signal density
Secondary role: preservation of separability as multiplexing expands
Composite encoding graph

MDWC

A control layer that stabilizes signal as systems scale

Electrochemical systems are powerful, but traditionally limited by drift, matrix effects, electrode differences, and fouling. MDWC dynamically controls waveform conditions to preserve peak separation, sharpen signal, and improve reproducibility under real sample conditions.

This is the control layer biological measurement has historically lacked. It allows Guanine to increase signal density without losing signal resolvability.

Primary role: signal strength and SNR preservation
Secondary role: maintenance of usable density under real-world variability
SWV scans with and without MDWC

Time-Series Phenotyping

Measurement extends from detection to dynamic biological function

Because Guanine signals are reversible and repeatedly measurable, the system can track biology over time. This extends the platform beyond static detection into functional readouts such as viability, treatment response, and phenotypic susceptibility.

This matters because it expands the platform from assay replacement into new categories of measurement where change over time is the signal of interest.

Primary role: dynamic functional measurement
Secondary role: extension of the platform into cartridge-based time-series testing
Time-series phenotyping graph

⭐ What This Enables

From isolated assays to a new class of measurement system

The result is not simply a better assay. It is a different class of measurement system that combines capabilities legacy platforms typically separate.

Measurement Capability

Multi-analyte measurement from a single sample and single instrument across analyte classes, with high signal density and strong per-analyte signal.

System Economics

Reader systems in the ~$6k range for multi-analyte testing and ~$8k for time-series-capable systems, without the capital burden of optical or sequencing platforms.

Deployment Model

Automated cartridge workflows reduce dependence on centralized labs, optics-heavy instruments, and technician-intensive operation.

New Measurement Modes

Time-series interrogation within a cartridge enables dynamic biology, including phenotyping and treatment-response measurement.


⭐ A More Technical View of the Architecture

A multi-layer signal system

Guanine can be understood as a stacked architecture in which each layer compounds the next.

Layer Function
Signal Primitive Electroactive quadruplex tags generate distinct reversible electrical signals
Signal Amplification High-density tag loading on particles increases signal per target
Sample Conditioning Filter concentration, selective lysis, enrichment, and cleanup improve analyte access and S:N
Encoding CME expands multiplex capacity through composite signal states
Control MDWC preserves signal integrity under real conditions
Resolution Multi-electrode arrays support parallel measurement and decoding
Output Structured electrical data supports multi-omic, time-series, software-defined measurement

The important point is that these are interacting architectural layers that allow measurement capability to scale without corresponding growth in hardware complexity.


⭐ What This Architecture Changes

From isolated assays to programmable measurement infrastructure

When biological measurement becomes signal-defined, improvements propagate across dimensions that legacy systems treat as tradeoffs.

Guanine is designed to align:

  • signal strength
  • multiplexing
  • analyte diversity
  • capital efficiency
  • turnaround time
  • portability
  • structured digital output
  • compatibility with software, AI, EMS/LIMS, and automated sampling environments

This is why the platform is relevant beyond a single assay category. It is a candidate infrastructure layer for distributed biological measurement across healthcare, industry, and time-series applications.

Dimension Legacy Systems Guanine Architecture
Signal Strength Often weak per event; amplification required High signal per target through dense reversible tags and enrichment
Multiplexing Channel-limited Encoding-based address space
Analyte Diversity Modality-specific Shared electrochemical core across analyte classes
Capital Cost Rises with capability Lower-cost fixed core with software-defined expansion
Cost per Test Labor and infrastructure heavy Parallelized, cartridge-based workflow
Turnaround Time Chemistry- or growth-limited Electrical measurement in minutes to hours
Mobility Often centralized Compact, optics-free deployment
Data Structure Fragmented by modality Structured digital signal outputs
Automation Potential Limited Compatible with integrated workflows and automated sampling

⭐ Comprehensive Intellectual Property

Defensibility Through Architecture

Guanine’s IP protects the architectural lock-in mechanism: the electroactive reversible quadruplex tag as a signal primitive, signal amplification, and the software-defined encoding and waveform control it enables.

The defensibility is not a single patent. It is the requirement that any competing system must replicate the full signal architecture—structures, methods, encoding, control, and workflow integration.


⭐ A New Frontier for Biological Measurement

Biology lacked a scaling law. Guanine is built to create one.

The core claim is not that Guanine is a faster assay or a cheaper instrument. It is that Guanine introduces an architecture in which biological measurement can begin to scale the way other information systems scaled: through standardized signal generation, combinatorial address space, and active control.

If that architecture holds, the consequence is not incremental improvement. It is a new frontier.